Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.
2.

Is NADH effective in the treatment of Parkinson's disease?

Swerdlow RH.

Drugs Aging. 1998 Oct;13(4):263-8. Review.

PMID:
9805207
3.

Strategy and tactic of modern Parkinson therapy.

Birkmayer W, Birkmayer GJ.

Acta Neurol Scand Suppl. 1989;126:63-6. Review.

PMID:
2694735
4.

Enzymatic stimulation and enzymatic inhibition in Parkinson's disease.

Nagatsu T.

Acta Neurol Scand Suppl. 1993;146:14-7. Review.

PMID:
8101411
5.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Deleu D, Hanssens Y, Northway MG.

Drugs Aging. 2004;21(11):687-709. Review.

PMID:
15323576
6.

Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Nyholm D.

Clin Pharmacokinet. 2006;45(2):109-36. Review.

PMID:
16485914
7.

New strategies in the treatment of early Parkinson's disease.

Rinne UK.

Acta Neurol Scand Suppl. 1991;136:95-8. Review.

PMID:
1801545
8.

Recent advances in pharmacological therapy of Parkinson's disease.

Riederer P, Lange KW, Youdim MB.

Adv Neurol. 1993;60:626-35. Review.

PMID:
8093582
9.

Anticholinergics for symptomatic management of Parkinson's disease.

Katzenschlager R, Sampaio C, Costa J, Lees A.

Cochrane Database Syst Rev. 2003;(2):CD003735. Review.

PMID:
12804486
10.

Clinical pharmacology of dopamine agonists in Parkinson's disease.

Lange KW.

Drugs Aging. 1998 Nov;13(5):381-9. Review.

PMID:
9829165

Supplemental Content

Support Center